Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: Cancer Res. 2016 Sep 2;76(22):6669–6679. doi: 10.1158/0008-5472.CAN-16-0571

Figure 1.

Figure 1

Figure 1A,B. Schema comparing SA-biotin multistep pretargeted radioimmunotherapy (PRIT) (A) and 2H7-Fc-C825 bispecific FP PRIT (B). Infusion of the anti-CD20 construct is followed by injection of a synthetic CA (N-acetylgalactosamine or DOTAY-dextran) and then infusion of the radiolabeled small molecule.